Highlights and Quick Summary
- Other current liabilities for the quarter ending September 30, 2022 was $23.5 Million (a 25.13% increase compared to previous quarter)
- Year-over-year quarterly Other current liabilities decreased by -47.15%
- Annual Other current liabilities for 2021 was $44.5 Million (a -39.32% decrease from previous year)
- Annual Other current liabilities for 2020 was $73.3 Million (a 705.43% increase from previous year)
- Annual Other current liabilities for 2019 was $9.1 Million (a 230.78% increase from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Other current liabilities of Beam Therapeutics Inc.
Most recent Other current liabilitiesof BEAM including historical data for past 10 years.Interactive Chart of Other current liabilities of Beam Therapeutics Inc.
Beam Therapeutics Inc. Other current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $23.51 | $18.79 | $30.94 | – |
| 2021 | $44.49 | $51.84 | $87.59 | $75.24 | $44.49 |
| 2020 | $73.32 | $18.23 | $20.9 | $12.16 | $73.32 |
| 2019 | – | – | – | $9.1 | $9.1 |
| 2018 | – | – | – | $16.5 | $2.75 |
| 2017 | – | – | – | – | $5.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology